1. Home
  2. SER vs VNRX Comparison

SER vs VNRX Comparison

Compare SER & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$3.25

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.27

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SER
VNRX
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.0M
38.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
SER
VNRX
Price
$3.25
$0.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$13.00
$3.17
AVG Volume (30 Days)
15.1K
2.8M
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$116,000.00
$1,472,007.00
Revenue This Year
$134.46
$55.33
Revenue Next Year
N/A
$493.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.48
52 Week Low
$3.12
$0.27
52 Week High
$7.92
$0.94

Technical Indicators

Market Signals
Indicator
SER
VNRX
Relative Strength Index (RSI) 29.79 31.94
Support Level $3.15 $0.28
Resistance Level $4.26 $0.31
Average True Range (ATR) 0.25 0.03
MACD -0.03 0.00
Stochastic Oscillator 0.09 3.40

Price Performance

Historical Comparison
SER
VNRX

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: